New patient enrolled in InVivo Therapeutics INSPIRE study

InVivo’s Neuro-spinal scaffold

A new patient has been enrolled into InVivo Therapeutics’ INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury) at Allegheny General Hospital in Pittsburgh, USA, part of the Allegheny Health Network (AHN).

Dan Altman, Nestor Tomycz, and Terrence Julien successfully performed the surgery and implantation approximately 21 hours after the injury occurred.

Julien, system co-director of Minimally Invasive Spine Surgery and principal investigator, said, “We are all hoping for the best possible outcome for this and all patients enrolled in the study. This will certainly be a landmark study and once again demonstrates the AHN Neurosurgery Department’s commitment to world class research endeavours brought to the Pittsburgh region.”

Mark Perrin, InVivo’s chief executive officer and chairman, says, “The patient is stable and the implantation procedure was a success. We now have 16 patients in follow up, and with the reported increase in spinal cord injury incidence during the summer months, we remain on track to complete enrolment into INSPIRE during the third quarter of this year.”


Please enter your comment!
Please enter your name here